Wyeth, the drugmaker being acquired by Pfizer Inc., must face a lawsuit by a woman who claims her breast cancer was caused by the menopause medicine Prempro, a Texas appeals court ruled.
The state appeals court in Houston said that Susan Brockert’s “failure-to-warn” claims aren’t preempted by federal drug-labeling regulations, overturning a district judge’s finding from February 2007. The case was sent back to the lower court for further proceedings.
The appeals panel cited last month’s U.S. Supreme Court decision upholding a $7 million award to a musician who lost her arm after being injected with Wyeth’s Phenergan nausea treatment. The high court said patients can sue drugmakers for failing to provide adequate safety warnings, even when a treatment and its packaging are approved by the U.S. Food and Drug Administration.